Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.7.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Stockholders' deficiency $ 3,834,770   $ 3,468,223
Research and development expenses $ 89,600 $ 36,450  
Outstanding Options [Member]      
Antidilutive securities 17,530,953 6,500,694  
Outstanding Warrants [Member]      
Antidilutive securities 18,455,264 10,967,879